// App-Quantinova.ai

[OP0199] : NO INCREASED RISK OF CONGENITAL MALFORMATIONS AFTER PRECONCEPTION PATERNAL EXPOSURE TO DMARDS

Researchers

Presenter

  • M. Wallenius

Principal Investigators

  • E. Lie

  • H. S. Koksvik

  • K. A. Salvesen

  • A. K. Daltveit

  • J. Skomsvoll

  • M. Ostensen

Medical Centers

  • Dept of Global Public Health and Primary Care, University of Bergen, Medical Birth Registry of Norway, Division of Epidemiology, Norwegian Institute of Public Health, Bergen, Norway

Locations

  • Norway

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Congenital disorder

Disease

  • Congenital anomalies

Biomarkers

  • Tumor necrosis factor

Drug/Treatment

  • Hydroxychloroquine

  • Sulfasalazine

  • Oraprine

  • Methotrexate

  • HWA-486

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved